FDA Inspection 1326372 — Linde Inc.
The FDA completed an inspection of Linde Inc. on Jun 17, 2026 in Suffield, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 17, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Suffield, CT (United States)